edith sim
edith sim
Pharmacology, Oxford
Verified email at pharm.ox.ac.uk
Cited by
Cited by
Metabolic gene polymorphism frequencies in control populations
S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ...
Cancer Epidemiology and Prevention Biomarkers 10 (12), 1239-1248, 2001
A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages
R Van der Geize, K Yam, T Heuser, MH Wilbrink, H Hara, MC Anderton, ...
Proceedings of the National Academy of Sciences 104 (6), 1947-1952, 2007
Nomenclature for N-acetyltransferases.
KP Vatsis, WW Weber, DA Bell, JM Dupret, DA Evans, DM Grant, ...
Pharmacogenetics 5 (1), 1-17, 1995
Complement activation and protein adsorption by carbon nanotubes
C Salvador-Morales, E Flahaut, E Sim, J Sloan, MLH Green, RB Sim
Molecular immunology 43 (3), 193-201, 2006
Metabolic polymorphisms and cancer susceptibility.
G Smith, LA Stanley, E Sim, RC Strange, CR Wolf
Cancer surveys 25, 27-65, 1995
The covalent-binding reaction of complement component C3
RB Sim, TM Twose, DS Paterson, E Sim
Biochemical Journal 193 (1), 115-127, 1981
Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer
A Risch, DMA Wallace, S Bathers, E Sim
Human molecular genetics 4 (2), 231-236, 1995
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease
ZS Nagy, MM Esiri, KA Jobst, C Johnston, S Litchfield, E Sim, AD Smith
Neuroscience 69 (3), 757-761, 1995
Structure of arylamine N-acetyltransferase reveals a catalytic triad
JC Sinclair, J Sandy, R Delgoda, E Sim, MEM Noble
Nature structural biology 7 (7), 560-564, 2000
N-Acetyltransferase polymorphism: comparison of phenotype and genotype in humans
D Hickman, E Sim
Biochemical pharmacology 42 (5), 1007-1014, 1991
Pharmacogenetics of the arylamine N-acetyltransferases
NJ Butcher, S Boukouvala, E Sim, RF Minchin
The pharmacogenomics journal 2 (1), 30-42, 2002
Phenotyping of human complement component C4, a class-III HLA antigen
E Sim, SJ Cross
Biochemical Journal 239 (3), 763-767, 1986
Expression of arylamine N-acetyltransferase in human intestine
D Hickman, J Pope, SD Patil, G Fakis, V Smelt, LA Stanley, M Payton, ...
Gut 42 (3), 402-409, 1998
Chromosomal localization of human genes for arylamine N-acetyltransferase
D Hickman, A Risch, V Buckle, NK Spurr, SJ Jeremiah, A McCarthy, E Sim
Biochemical Journal 297 (3), 441-445, 1994
Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid …
M Payton, R Auty, R Delgoda, M Everett, E Sim
Journal of bacteriology 181 (4), 1343-1347, 1999
Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies
P Vineis, D Marinelli, H Autrup, J Brockmoller, I Cascorbi, AK Daly, ...
Cancer Epidemiology and Prevention Biomarkers 10 (12), 1249-1252, 2001
Purification of human C3b inactivator by monoclonal-antibody affinity chromatography
L Hsiung, AN Barclay, MR Brandon, E Sim, RR Porter
Biochemical Journal 203 (1), 293, 1982
Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with α 2-macroglobulin
RB Sim, E Sim
Biochemical Journal 193 (1), 129-141, 1981
Update on consensus arylamine N-acetyltransferase gene nomenclature
DW Hein, DM Grant, E Sim
Pharmacogenetics and Genomics 10 (4), 291-292, 2000
Arylamine N-Acetyltransferase-1 Is Highly Expressed in Breast Cancers and Conveys Enhanced Growth and Resistance to Etoposide in Vitro
PJ Adam, J Berry, JA Loader, KL Tyson, G Craggs, P Smith, J De Belin, ...
Molecular cancer research 1 (11), 826-835, 2003
The system can't perform the operation now. Try again later.
Articles 1–20